Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 4—April 2018

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016

Charlene M.C. RodriguesComments to Author , Jay Lucidarme, Ray Borrow, Andrew Smith, J. Claire Cameron, E. Richard Moxon, and Martin C.J. Maiden
Author affiliations: University of Oxford, Oxford, UK (C.M.C. Rodrigues, E.R. Moxon, M.C.J. Maiden); Public Health England, Manchester, UK (J. Lucidarme, R. Borrow); Glasgow Royal Infirmary, Glasgow, Scotland, UK (A. Smith); University of Glasgow, Glasgow (A. Smith); Health Protection Scotland, Glasgow (J.C. Cameron)

Main Article

Table 2

Number of unique BASTs and measures of diversity among invasive meningococcal disease isolates, United Kingdom, 2010–2016*

Epidemiologic year No. unique BASTs No. isolates No. BASTs/isolate Simpson index of diversity
2010−11 229 550 0.416 0.976
2011–12 187 439 0.426 0.977
2012–13 226 491 0.460 0.976
2013–14 181 436 0.415 0.960
2014–15 199 572 0.348 0.924
Total 803 3,073 0.261 0.963

*BASTs, Bexsero Antigen Sequence Types.

Main Article

Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.